Abstract:BACKGROUND/AIMS:The etiology of asthma, which is a complicated disorder with various symptoms, including wheezing, coughing, and airflow obstruction, remains poorly understood. In addition, the effects of microRNAs (miRs) have not been explored. This study explored the effect of microRNA-200a (miR-200a) on airway smooth muscle cells (ASMCs) and airway remodeling in asthmatic mice. Furthermore, we speculated that miR-200a achieves its effect by targeting FOXC1 via the PI3K/AKT signaling pathway based on differentially expressed gene screening, target miR predictions and a bioinformatics analysis.METHODS:Eighty mice were assigned to a saline group or an ovalbumin (OVA) group, and the OVA group was transfected with a series of inhibitors, activators, and siRNAs to test the established mouse model. Airway reactivity and the ratio of eosinophils (EOSs) to leukocytes were detected. An ELISA was adopted to measure the levels of interleukin (IL)-4, IL-6, IL-8, tumor necrosis factor (TNF)-α, and immunoglobulin E (IgE). Reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blotting were used to determine the expression of FOXC1, PI3K, AKT, NF-κB, cyclin D1, TGF-β1 and p-AKT in ASMCs. Finally, CCK-8 assays were performed to detect cell proliferation and flow cytometry to detect apoptosis and cell cycle entry.RESULTS:The bioinformatics analysis indicated that miR-200a mediated the PI3K/AKT signaling pathway by targeting FOXC1. In addition, mouse models of asthma were established. An elevated expression of miR-200a, a decreased mRNA and protein expression of FOXC1, PI3K, AKT, NF-κB, cyclin D1 and TGF-β1, a decreased expression of p-AKT, suppressed cell proliferation, accelerated apoptosis, and an increased number of cells at the G0/G1 phase were observed following the upregulation of miR-200a and downregulation of FOXC1.CONCLUSION:The overexpression of miR-200a may downregulate FOXC1, thereby inhibiting the activation of the PI3K/AKT signaling pathway and ultimately suppressing ASMC proliferation and airway remodeling in asthmatic mice. This evidence supports the potential that miR-200a represents a new approach to treating asthma.

MiR-200a and miR-200b restrain inflammation by targeting ORMDL3 to regulate the ERK/MMP-9 pathway in asthma

MicroRNA in Children with Asthma: Findings from Bronchoalveolar Lavage Fluid

MicroRNA-200a Affects the Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 Via the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice.

Microrna-22-3p Plays A Protective Role In A Murine Asthma Model Through The Inhibition Of The Nlrp3-Caspase-1-Il-1 Beta Axis

MiR-143-3p Controls TGF-β1-induced Cell Proliferation and Extracellular Matrix Production in Airway Smooth Muscle Via Negative Regulation of the Nuclear Factor of Activated T Cells 1.

Micrornas And Asthma Regulation

Follistatin-related protein 1 in asthma: miR-200b-3p interactions affect airway remodeling and inflammation phenotype

MiR-506 Targets Polypyrimidine Tract-Binding Protein 1 to Inhibit Airway Inflammatory Response and Remodeling Via Mediating Wnt/β-catenin Signaling Pathway.

MiRNA-192-5p Attenuates Airway Remodeling and Autophagy in Asthma by Targeting MMP-16 and ATG7.

Mir-128-3p Alleviates Airway Inflammation in Asthma by Targeting SIX1 to Regulate Mitochondrial Fission and Fusion.

MicroRNA-485-3p promotes the inflammatory response and extracellular matrix deposition by activating Wnt/?-catenin signaling in human airway smooth muscle cells

MiR-365-3p is a negative regulator in IL-17-mediated asthmatic inflammation

Regulation of Cbl and Esr1 Expression by Microrna-22-3p, 513A-5P and 625-5P May Impact the Pathogenesis of Dust Mite-Induced Pediatric Asthma

MicroRNA-155 differentially regulates IL-13Rα1 and IL-13Rα2 expression and signaling that drives abnormal epithelial cells functions in severe asthma

MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells

MicroRNA-885-3p alleviates bronchial epithelial cell injury induced by lipopolysaccharide via toll-like receptor 4

LncRNA NEAT1 regulates MMP-16 by targeting miR-200a/b to aggravate inflammation in asthma

ORMDL3 Promotes Angiogenesis in Chronic Asthma Through the ERK1/2/VEGF/MMP-9 Pathway

Effect of miR-506-3p on Proliferation and Apoptosis of Airway Smooth Muscle Cells in Asthmatic Mice by Regulating CCL2 Gene Expression and Mediating TLR4/NF-κB Signaling Pathway Activation

MicroRNA Mir-146A-5p Inhibits the Inflammatory Response and Injury of Airway Epithelial Cells Via Targeting TNF Receptor-Associated Factor 6

Methylation Status of ORMDL3 Regulates Cytokine Production and P-Erk/mmp9 Pathway Expression